CN110042153A - A kind of detection method and its primer sets of SMN1 gene mutation - Google Patents

A kind of detection method and its primer sets of SMN1 gene mutation Download PDF

Info

Publication number
CN110042153A
CN110042153A CN201810040639.0A CN201810040639A CN110042153A CN 110042153 A CN110042153 A CN 110042153A CN 201810040639 A CN201810040639 A CN 201810040639A CN 110042153 A CN110042153 A CN 110042153A
Authority
CN
China
Prior art keywords
seq
primer
smn1 gene
sma
primer sets
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201810040639.0A
Other languages
Chinese (zh)
Inventor
裘敏燕
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Union Medical Laboratory Co Ltd
Original Assignee
Shanghai Union Medical Laboratory Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Union Medical Laboratory Co Ltd filed Critical Shanghai Union Medical Laboratory Co Ltd
Priority to CN201810040639.0A priority Critical patent/CN110042153A/en
Publication of CN110042153A publication Critical patent/CN110042153A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/6858Allele-specific amplification

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The present invention relates to molecular biology gene technology field and medical domains, specifically disclose a kind of for detecting the method and its primer sets of SMN1 gene mutation.The present invention analyzes the nucleic acid sequence of spinal muscular atrophy (SMA) correlation SMN1 gene extron 7 and 8 deletion mutation region of exon, design corresponding primer, multiplexed PCR amplification is passed through to sample genomic dna specific site, is finally detected with Ion Torrent semiconductor chip sequencing technologies.The advantages that detection method of the invention has flux big, specificity and high sensitivity, as a result stable, reproducible, and detection speed is fast.For SMA science of heredity in terms of detection, test, analysis and assessment provide a quick, reliable and accurate new way, to provide fundamental basis for the clinical diagnosis of such disease.

Description

A kind of detection method and its primer sets of SMN1 gene mutation
Technical field
The present invention relates to molecular biology gene technology field and medical domain, it is related to molecular biology method to SMN1 The primer sets of gene mutation site detection, in particular to it is prominent to SMN1 gene with Ion Torrent semiconductor chip sequencing technologies Displacement point carries out the relevant primer group and its kit of qualitative and quantitative analysis.
Background technique
Spinal muscular atrophy (Spinal Muscular Atrophy, SMA) is that the most common lethal autosome is hidden One of property hereditary disease.Illness rate is 1/6000~1/10000, occupies the second of lethal autosomal recessive hereditary diseases.Spinal cord Property muscular atrophy be sometimes referred to as " progressive spinal myodystrophia disease " or " spinal muscular atrophy ".
In neuromuscular hereditary disease, SMA belongs to typical neurogenic urinary incontinence disease and in infancy and childhood The most common neurogenic urinary incontinence of morbidity leads to the disease of Delayed motor.SMA patient causes to transport due to inhereditary material defect Dynamic neuronal development obstacle falls to main performance with locomitivity so that symmetry limb muscle is powerless.Most of SMA patients exist It falls ill in 2 years old, patient will not walk, stand, and severe patient can not even come back, and completely lose locomitivity.Most of SMA suffer from Person is dead because of extremely weak and respiratory failure between 2-10 years old, and patient with severe symptoms can only survive some months.It therefore is a kind of Seriously endanger the hereditary disease of life.SMA according to age of onset difference, can be divided into SMA I, SMA II, SMA III, SMA IV and SMA V-type.
SMA is primarily due to caused by the SMN homozygous Deletion of 5q11.2-13.3.SMA patient can be diagnosed to be SMN1 Gene has the situation of large fragment deletion to occur and (include at least whole section of exon7 even exon8).Wherein most SMA type I Homozygous deletion mutation (homozygous deletion) has occurred in the SMN1 gene of patient;Many SMA type II patients its Deletion mutation occurs for a set of SMN gene, and another set of SMN gene changes, and (conversion, SMN1 gene conversion are at SMN2 base Cause);The patient of SMA type III, two sets of SMN1 genes may all be transformed into SMN2 gene.SMN base is not found as minority Because of large fragment deletion or the SMA patient of conversion, then some micromutations may occur on SMN gene and cause a disease.It follows that by The copy number that SMN1 gene is detected by DNA molecular diagnostic techniques, can be used as whether diagnosis is the one of SMA patient or carrier Item important evidence.
United States Medicine science of heredity has some clinical guidelines and the preventative strategies of common genetic disease is illustrated, and SMA is Recommend one of the disease that all Mr. and Mrs are carried out with screening.According to a large amount of data research, SMA Disease-causing gene is taken in crowd Band rate about just has a SMA carrier in 1/40, that is, every 40 normal persons.There is a batch to District of Shanghai pregnant woman to grind It is also similar to study carefully data.
The deletion condition of SMN1 gene extron 7 and exon 8 in SAM patient, occurs exon 7 and exon 8 lacks (Zhan Renqun 87%) or the individually ratio (the 7% of Zhan Renqun ratio) of exon 7 missing, occur the ratio about 94% of Exon deletion [1], so the deletion condition of detection SMN1 gene extron 7 and exon 8 is diagnosis spinal muscular atrophy key evidence.
Detection SAM correlation SMN1 gene extron 7 and the method for 8 deletion mutation of exon mainly have MLPA, PCR- at present The problems such as RFLP, DHPLC etc., there are complicated for operation, flux is low, cost is expensive.
Ion Torrent semiconductor chip sequencing technologies are the sequencing technologies of a new generation, its core technology is using half Conductor technology establishes direct connection between chemistry and digital information.It is fixed on the microballoon in the micropore of semiconductor chip DNA chain then successively mixes mononucleotide dGTP, dCTP, dATP, dTTP.With the incorporation of each base, H is released+, H+? They can be detected when passing through each hole bottom, by H+Detection, real-time interpretation base.Due to its chemistry sequencing principle Naturally simple, literalness nucleotide, without laser or optical detection apparatus, thus can reach minimum sequencing deviation and outstanding Sequencing cover equilibrium degree, an instrument can be suitble to the scientific research of various sequencing throughput demands, obtain in a relatively short period of time Obtain true and reliable experimental result.
Ion Torrent semiconductor chip sequencing technologies are compared with tradition Sanger method and two generation sequencing technologies, Ion Torrent technology has following advantage: system is without laser light source, no optical system, no photographic system;Use unmarked nucleotide And enzyme is sequenced, background interference is low;By to H+Detection, base interpretation accuracy can be improved;Sequencing throughput is big, fast Degree is fast, and it is thousands of times or more of traditional Sanger sequencing approach flux, together that the sequencing detection for completing 1G flux, which only needs 2 ~ 3 hours, When compensate for too long defect of existing high-flux sequence method working time in two generations.
At present still without report Ion Torrent semiconductor chip sequencing technologies dedicated for the inspection of SMN1 gene mutation It surveys.
Summary of the invention
The purpose of the invention is to make up the deficiencies in the prior art, provide for the qualitative, quantitative of SMN1 gene mutation The method and its primer of detection.
To solve the above problems, the present invention takes following technical scheme:
It is gained knowledge and relevant bioinformatics software using biological information, it is related to the SAM that can be retrieved in public database 8 deletion mutation site of SMN1 gene extron 7 and exon, with 5.0 software design PCR of Primer Express Software Primer.
It is by SEQ ID NO:1 in sequence table and SEQ ID NO for detecting the primer of SMN1 gene order segment 1: The primer pair of 2 compositions.
Upstream primer: the SEQ ID of 5 '-agtagaattaagactatcaacttaatttctgatca -3 ' No:1;
Downstream primer: the SEQ ID of 5 '-ccttccttctttttgattttgttt -3 ' No:2.
It is by SEQ ID NO:3 in sequence table and SEQ ID NO for detecting the primer of SMN1 gene order segment 2: The primer pair of 4 compositions.
Upstream primer: the SEQ ID of 5 '-agtagaattagtaataaccaaatgcaatgtgaa -3 ' No:3;
Downstream primer: the SEQ ID of 5 '-ctacaacacccttctcacag -3 ' No:4.
It is by SEQ ID NO:5 in sequence table and SEQ ID NO for detecting the primer of SMN1 gene order segment 3: The primer pair of 6 compositions.
Upstream primer: the SEQ ID of 5 '-agtagaattacctttattttccttacagggttt -3 ' No:5;
Downstream primer: the SEQ ID of 5 '-agtaatgtgagcaccttccttct -3 ' No:6.
It is by SEQ ID NO:7 in sequence table and SEQ ID NO for detecting the primer of SMN1 gene order segment 4: The primer pair of 8 compositions.
Upstream primer: the SEQ ID of 5 '-agtagaattaggaatgggtaactcttcttgatta -3 ' No:7;
Downstream primer: the SEQ ID of 5 '-ttctcaactgcctcaccacc -3 ' No:8.
PCR amplification is carried out to sample to be detected with above-mentioned primer sets using the method for multiplex PCR.
It is micro- that pcr amplification product is subjected to the amplification building of sublibrary, ISP(Ion Sphere Particles, Ion Ball) template preparation, be sequenced in Ion Torrent PGM system, and related sequencing sequence is analyzed with software.
The present invention is using multiple PCR method combination Ion Torrent semiconductor chip sequencing technologies simultaneously to SAM correlation SMN1 gene extron 7 and 8 deletion mutation site of exon carry out parallel detection, and the range of the detection covers about 90% or more SAM patient's SMN1 gene delection situation.Testing result can be used for the auxiliary diagnosis or screening of SAM.It is advantageous that flux is big, Specificity and high sensitivity, it is as a result stable, it is reproducible, detect fireballing advantage.
Specific embodiment
The present invention is described further in conjunction with specific embodiments.It should be understood that these embodiments are for illustration purposes only, without For limiting the scope of the invention.
Embodiment 1, for SMN1 detection in Gene Mutation primer sets design.
It is gained knowledge and relevant bioinformatics software using biological information, to the SAM that can be retrieved in public database 8 deletion mutation site of related SMN1 gene extron 7 and exon, is set with 5.0 software of Primer Express Software PCR primer is counted, primer sequence is as follows.
It is by SEQ ID NO:1 in sequence table and SEQ ID NO for detecting the primer of SMN1 gene order segment 1: The primer pair of 2 compositions.
Upstream primer: the SEQ ID of 5 '-agtagaattaagactatcaacttaatttctgatca -3 ' No:1;
Downstream primer: the SEQ ID of 5 '-ccttccttctttttgattttgttt -3 ' No:2.
It is by SEQ ID NO:3 in sequence table and SEQ ID NO for detecting the primer of SMN1 gene order segment 2: The primer pair of 4 compositions.
Upstream primer: the SEQ ID of 5 '-agtagaattagtaataaccaaatgcaatgtgaa -3 ' No:3;
Downstream primer: the SEQ ID of 5 '-ctacaacacccttctcacag -3 ' No:4.
It is by SEQ ID NO:5 in sequence table and SEQ ID NO for detecting the primer of SMN1 gene order segment 3: The primer pair of 6 compositions.
Upstream primer: the SEQ ID of 5 '-agtagaattacctttattttccttacagggttt -3 ' No:5;
Downstream primer: the SEQ ID of 5 '-agtaatgtgagcaccttccttct -3 ' No:6.
It is by SEQ ID NO:7 in sequence table and SEQ ID NO for detecting the primer of SMN1 gene order segment 4: The primer pair of 8 compositions.
Upstream primer: the SEQ ID of 5 '-agtagaattaggaatgggtaactcttcttgatta -3 ' No:7;
Downstream primer: the SEQ ID of 5 '-ttctcaactgcctcaccacc -3 ' No:8.
Barcode sequence of the end of upstream primer 5 ' of each detection sequence segment comprising one section of sample information for identification 5’- agtagaatta -3’。
Embodiment 2, SMN1 gene mutation detection.
1) acquisition of sample genomic dna
The genomic DNA of whole blood sample is extracted with Qiagen DNA extraction agent box.
2) amplification and sequencing of PCR
The sample genomic dna extracted using step 1) is template, under the guidance of the primer described in embodiment 1, carries out multiplex PCR expansion Increase (95 DEG C of 5 min;95 DEG C of 15 s, 60 DEG C of 1 min, totally 40 recycle), the amplified production of acquisition successively carries out amplicon The building in library, ISP(Ion Sphere Particles, Ion microballoon) template preparation and chip loading and in Ion It is sequenced in Torrent PGM system.
3) it analyzes and obtains conclusion
Sequencing result is analyzed with IGV2.0 software, counts the reading sequence of SMN1 genetic fragment as a result, according to testing result really Whether random sample originally has SMN1 gene mutation, and if any mutation, then prompt is mutated concrete condition, such as " subject in interpretation of result Homozygous deletion occurs for SMN1 gene extron 7 ";Such as without mutation, then " subject's SMN1 exon 7 is prompted in structural analysis Homozygous deletion does not occur with exon 8, prompts normal ".
This detection detects 1 sample altogether, and testing result and conclusion see the table below.
Sequence table
<110>Shanghai joins Co., Ltd, lucky medical test institute
<120>a kind of detection method and its primer sets of SMN1 gene mutation
<160> 8
<170> SIPOSequenceListing 1.0
<210> 1
<211> 35
<212> DNA
<213>artificial sequence (Artificial Sequence)
<400> 1
agtagaatta agactatcaa cttaatttct gatca 35
<210> 2
<211> 24
<212> DNA
<213>artificial sequence (Artificial Sequence)
<400> 2
ccttccttct ttttgatttt gttt 24
<210> 3
<211> 33
<212> DNA
<213>artificial sequence (Artificial Sequence)
<400> 3
agtagaatta gtaataacca aatgcaatgt gaa 33
<210> 4
<211> 20
<212> DNA
<213>artificial sequence (Artificial Sequence)
<400> 4
ctacaacacc cttctcacag 20
<210> 5
<211> 33
<212> DNA
<213>artificial sequence (Artificial Sequence)
<400> 5
agtagaatta cctttatttt ccttacaggg ttt 33
<210> 6
<211> 23
<212> DNA
<213>artificial sequence (Artificial Sequence)
<400> 6
agtaatgtga gcaccttcct tct 23
<210> 7
<211> 34
<212> DNA
<213>artificial sequence (Artificial Sequence)
<400> 7
agtagaatta ggaatgggta actcttcttg atta 34
<210> 8
<211> 20
<212> DNA
<213>artificial sequence (Artificial Sequence)
<400> 8
ttctcaactg cctcaccacc 20

Claims (3)

1. a kind of method and its primer sets for detecting SMN1 gene mutation, specific steps are as follows:
It is gained knowledge and relevant bioinformatics software using biological information, it is related to the SMA that can be retrieved in public database 8 deletion mutation site of SMN1 gene extron 7 and exon, with 5.0 software design PCR of Primer Express Software Primer;
PCR amplification is carried out to sample to be detected using the method for multiplex PCR;
Pcr amplification product is carried out to the building of amplification sublibrary, ISP(Ion Sphere Particles, Ion microballoon) mould The preparation of plate is sequenced in Ion Torrent PGM system, and is analyzed with software related sequencing sequence.
2. a kind of method and its primer sets for detecting SMN1 gene mutation as described in claim 1, which is characterized in that described PCR primer group includes the primer for 4 SMN1 gene order segments, and sequence is respectively as follows: SEQ ID No:1-SEQ ID No:8:
5'- agtagaattaagactatcaacttaatttctgatca -3' SEQ ID No: 1;
5'- ccttccttctttttgattttgttt -3' SEQ ID No: 2;
5'- agtagaattagtaataaccaaatgcaatgtgaa -3' SEQ ID No: 3;
5'- ctacaacacccttctcacag -3' SEQ ID No: 4;
5'- agtagaattacctttattttccttacagggttt -3' SEQ ID No: 5;
5'- agtaatgtgagcaccttccttct -3' SEQ ID No: 6;
5'- agtagaattaggaatgggtaactcttcttgatta -3' SEQ ID No: 7;
5’- ttctcaactgcctcaccacc -3’ SEQ ID No: 8。
3. for a kind of method and its primer sets for detecting SMN1 gene mutation as described in claim 1, which is characterized in that described Primer sets form it is a kind of detect SMN1 gene mutation kit.
CN201810040639.0A 2018-01-16 2018-01-16 A kind of detection method and its primer sets of SMN1 gene mutation Pending CN110042153A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201810040639.0A CN110042153A (en) 2018-01-16 2018-01-16 A kind of detection method and its primer sets of SMN1 gene mutation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201810040639.0A CN110042153A (en) 2018-01-16 2018-01-16 A kind of detection method and its primer sets of SMN1 gene mutation

Publications (1)

Publication Number Publication Date
CN110042153A true CN110042153A (en) 2019-07-23

Family

ID=67272932

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201810040639.0A Pending CN110042153A (en) 2018-01-16 2018-01-16 A kind of detection method and its primer sets of SMN1 gene mutation

Country Status (1)

Country Link
CN (1) CN110042153A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111172254A (en) * 2020-03-19 2020-05-19 浙江中创生物医药有限公司 Detection method and kit for SMN1 gene mutation
CN113308538A (en) * 2021-06-29 2021-08-27 广东博奥医学检验所有限公司 SMA detection method based on sanger sequencing

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111172254A (en) * 2020-03-19 2020-05-19 浙江中创生物医药有限公司 Detection method and kit for SMN1 gene mutation
CN111172254B (en) * 2020-03-19 2023-09-08 浙江中创生物医药有限公司 Detection method and kit for SMN1 gene mutation
CN113308538A (en) * 2021-06-29 2021-08-27 广东博奥医学检验所有限公司 SMA detection method based on sanger sequencing

Similar Documents

Publication Publication Date Title
CN111440884B (en) Intestinal flora for diagnosing sarcopenia and application thereof
CN108603232A (en) Monitor treatment or the progress of myeloma
CN106434870A (en) ncRNA and uses thereof
CN110029158A (en) A kind of marfan&#39;s syndrome detection panel and its application
CN106591273A (en) Gene new mutations relevant to IEM (Inborn Errors of Metabolism) and detection kit
KR20160080165A (en) Neurodegenerative disease diagnostic composition and method using the same
JP2021501592A (en) Gene regulation
US20230058214A1 (en) Identification of Unique Blood-Based Gene Expression Profiles in Children with Regressive Autism Spectrum Disorder (ASD) and Ileocolitis
CN110042153A (en) A kind of detection method and its primer sets of SMN1 gene mutation
CN108715893B (en) SNP markers related to radioactive brain injury caused by radiotherapy and application thereof
CN105803054A (en) Kit and use thereof in detection of orofacial clefts related genes
CN109825574A (en) A kind of multiple gene detection kit and its application method for antiepileptic medication guide
CN112251507A (en) Microorganism relevant to cerebral apoplexy diagnosis and treatment effect evaluation
CN105442053B (en) A kind of DNA library of checkout and diagnosis ion channel disease Disease-causing gene and its application
CN104232650B (en) The new Disease-causing gene of idiopathic calcification of basal ganglion and its encoding proteins matter and application
CN104120186B (en) Congenital hypothyroidism polygenes sequencing primer and detection method
WO2021230379A1 (en) Method for detecting parkinson disease
CN105838720A (en) PTPRQ gene mutant and application thereof
Jeon et al. Transcriptomic profiles and their correlations in saliva and gingival tissue biopsy samples from periodontitis and healthy patients
CN114381525A (en) Group of molecular markers for glioma prognosis typing and typing method and application thereof
CN110144390A (en) A kind of detection method and its primer sets of PAH gene mutation
CN113846157B (en) Application of human SERPINA3 gene in wine dependence screening
CN104250649B (en) The new Disease-causing gene of the white first syndrome of the few hair of Keratoderma and its encoding proteins matter and application
CN109022592A (en) SNP marker and its application for four kinds of common strain rats identifications
CN112048552B (en) Intestinal flora for diagnosing myasthenia gravis and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20190723